Date ▲ Holder Code Drug Date from Subject 2.2.2023 BIOMEDICA spol. s r.o. (BCS) 67133 BIOTUSSIL (gtt por 1x100 ml (liek.skl.hnedá)) 1.2.2023 R 2.2.2023 Exeltis Slovakia s.r.o. (EET) 1560D Endovelle 2 mg tablety (tbl 1x28x2 mg (blis.Al/PVC/PVDC-kalendár.bal.)) 2.2.2023 O 2.2.2023 STADA Arzneimittel AG (STD) 4414C Perindamlostad 8 mg/10 mg tablety (tbl 30x8 mg/10 mg (blis.Al/Al)) 27.1.2023 O 2.2.2023 STADA Arzneimittel AG (STD) 4416C Perindamlostad 8 mg/10 mg tablety (tbl 90x8 mg/10 mg (blis.Al/Al)) 27.1.2023 O 1.2.2023 Sanofi Pasteur (SNP-F-8) 34364 STAMARIL (plv iul 1x1 dávka+1x0,5 ml solv. (liek.inj.skl.+striek.inj.napln. s pripojenou ihlou)) 30.1.2023 R 1.2.2023 Sanofi Pasteur (SNP-F-8) 86403 Typhim Vi (sol inj 1x0,5 ml (striek.inj.skl.napl.)) 1.2.2023 R 1.2.2023 Merck Europe B.V. (MCK-NL) 02735 Rebif 8,8 mikrogramov injekčný roztok v naplnenom pere, Rebif 22 mikrogramov injekčný roztok v naplnenom pere (sol inj 6x0,2 ml /8,8 µg +6x0,5 ml/22 µg (pero napln.)) 1.6.2023 Z 1.2.2023 CSL Behring GmbH (CSL) 50935 Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml (liek.inj.skl.)) 1.2.2023 R 1.2.2023 Angelini Pharma Österreich GmbH (ANG-AT-1) 14162 TANTUM VERDE Mint (pas ord 20x3 mg (obal papier)) 26.1.2023 O 1.2.2023 Johnson & Johnson, s.r.o. (JHN-SK-1) 41194 Topamax 50 (tbl flm 60x50 mg (blis.Al/Al)) 30.4.2023 Z 1.2.2023 Johnson & Johnson, s.r.o. (JHN-SK-1) 41198 Topamax 100 (tbl flm 60x100 mg (blis.Al/Al)) 30.4.2023 Z 1.2.2023 Viatris Healthcare Limited (VIM-1) 26443 Fevarin 100 (tbl flm 30x100 mg (blis.PVC/PVDC/Al)) 6.2.2023 R 1.2.2023 Viatris Limited (VIM) 6931B Cinacalcet Viatris 30 mg filmom obalené tablety (tbl flm 28x30 mg (blis.Al/PVDC/PVC)) 6.2.2023 R 1.2.2023 BIOMIN, a.s. (BMN-1) 28720 CYNT 0,2 (tbl flm 30x0,2 mg (blis.PVC/PVDC/ALU)) 1.2.2023 O 1.2.2023 Accord Healthcare Polska Sp. z o.o. (AOK) 76907 Midazolam Accord 5 mg/ml (sol ijf 10x1 ml/5 mg (amp.skl.)) 1.2.2023 O
